Key Highlights Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and obesity treatment, sold under Ozempic®, Wegovy®, and Rybelsus®.…
Active Pharmaceutical Ingredients (API)BrazilEuropeEurope Medicine Agency (EMA)Global MarketIndiaIntellectual Property (IP)JapanLaunchPatent LitigationPharma Science & ResearchRegulatoryU.S FDAUSA